Adaptive Biotechnologies Corporation (ADPT) News
Track canonical SquawkNews coverage tagged to ADPT, Adaptive Biotechnologies Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ADPT - Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
ADPT - Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
EARNINGS | Jul 29, 2026, 08:06 PM UTC
L
ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $
ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $-0.25, Q2 Operating Income $-15.77M, Q2 ADJ EBITDA $-700 thousand
EARNINGS | Jul 29, 2026, 08:06 PM UTC
L
Adaptive Biotechnologies Insider Sold Shares Worth $8,501,149, According to a Recent SEC Filing
() -- Harlan S Robins, Chief Scientific Officer, on July 02, 2026, sold 386,240 shares in Adaptive Biotechnologies (ADPT) for $8,501,149. Following the Form 4 filing with the SEC, Robins has control over a total of 1,019
REGULATION | Jul 08, 2026, 07:35 AM UTC
L
Adaptive Biotechnologies Insider Sold Shares Worth $2,157,683, According to a Recent SEC Filing
() -- Francis Lo, Chief People Officer, on July 01, 2026, sold 95,842 shares in Adaptive Biotechnologies (ADPT) for $2,157,683. Following the Form 4 filing with the SEC, Lo has control over a total of 233,213 common shar
REGULATION | Jul 07, 2026, 07:58 AM UTC